Skip to main content
. 2022 Oct 6;11(19):5894. doi: 10.3390/jcm11195894

Table 3.

Final Diagnosis of Study Population.

Diagnosis Age ≥ 80 (n = 45) Age < 80 (n = 183)
Lung cancer 37 (82.2%) 147 (80.3%)
Adenocarcinoma 25 (55.6%) 84 (45.9%)
Squamous cell carcinoma 8 (17.8%) 36 (19.7%)
NSCLC, NOS 4 (8.9%) 21 (11.5%)
Small cell carcinoma 0 (0%) 5 (2.7%)
Metastasis 1 (2.2%) 8 (4.4%)
Other malignancy 1 (2.2%) 6 (3.3%)
Benign 6 (13.3%) 23 (12.6%)
Tuberculosis 3 (6.7%) 10 (5.5%)
Pneumonia or others 3 (6.7%) 13 (7.1%)

NSCLC, non-small-cell lung cancer; NOS, not otherwise specified.